期刊文献+

Do probiotics have a therapeutic role in gastroenterology? 被引量:6

Do probiotics have a therapeutic role in gastroenterology?
下载PDF
导出
摘要 Several hundred species of bacteria inhabit the gut, and affect its cell biology, morphology and homeostasis. Many bacteria are however potential pathogens, especially if the integrity of the epithelial barrier is physically or functionally breached. Conversely, the interaction between host and commensal microbes can confer important health benefits. This has led to commercial and public interest in 'probiotics', live microbes principally taken as food supplements. Might probiotics also be used in disease therapy? Experimental evidence that probiotics modulate gut physiology, particularly barrier integrity and immunological function, underpins exciting new gastroenterological research. We discuss below the scientific basis for probiotic effects and present a critical perspective for their use in relation to gastrointestinal disease. Several hundred species of bacteria inhabit the gut, and affect its cell biology, morphology and homeostasis. Many bacteria are however potential pathogens, especially if the integrity of the epithelial barrier is physically or functionally breached. Conversely, the interaction between host and commensal microbes can confer important health benefits. This has led to commercial and public interest in ’probiotics’, live microbes principally taken as food supplements. Might probiotics also be used in disease therapy? Experimental evidence that probiotics modulate gut physiology, particularly barrier integrity and immunological function, underpins exciting new gastroenterological research. We discuss below the scienti?c basis for probiotic effects and present a critical perspective for their use in relation to gastrointestinal disease.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第34期5447-5457,共11页 世界胃肠病学杂志(英文版)
关键词 PROBIOTICS GASTROENTEROLOGY 前生命期 胃肠病学 治疗 病理机制
  • 相关文献

参考文献1

二级参考文献26

  • 1[1]Bakir AA,Levy PS,Dunea G.The prognosis of lupus nephritis in African-Americans:a retrospective analysis.Am J Kidney Dis 1994;24:159-171
  • 2[2]Miwa H,Nagahara A,Sato K,Ohkura R,Murai T,Shimizu H,Watanabe S,Sato N.Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.J Gastroenterol Hepatol 1999;14:317-321
  • 3[3]Labenz J,Stolte M,Peitz U,Tillenburg B,Becker T,Borsch G.One-week triple therapy with omeprazole,amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection.Aliment Pharmacol Ther 1996;10:207-210
  • 4[4]Wurzer H,Rodrigo L,Stamler D,Archambault A,Rokkas T,Skandalis N,Fedorak R,Bazzoli F,Hentschel E,Mora P,Archimandritis A,Megraud F.Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer.ACT-10Study Group.Aliment Pharmacol Ther 1997;11:943-952
  • 5[5]Lind T,Veldhuyzen van Zanten S,Unge P,Spiller R,Bayerdorffer E,O'Morain C,Bardhan KD,Bradette M,Chiba N,Wrangstadh M,Cederberg C,Idstrom JP.Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials:the MACH I Study.Helicobacter 1996;1:138-144
  • 6[6]Armuzzi A,Cremonini F,Bartolozzi F,Canducci F,Candelli M,Ojetti V,Cammarota G,Anti M,De Lorenzo A,Pola P,Gasbarrini G,Gasbarrini A.The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal sideeffects during Helicobacter pylori eradication therapy.Aliment Pharmacol Ther 2001;15:163-169
  • 7[7]Gorbach SL.Lactic acid bacteria and human health.Ann Med 1990;22:37-41
  • 8[8]Seki H,Shiohara M,Matsumura T,Miyagawa N,Tanaka M,Komiyama A,Kurata S.Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI.Pediatr Int 2003;45:86-90
  • 9[9]Kamiya S,Taguchi H,Yamaguchi H,Osaki T,Takahashi M,Nakamura S.Bacterioprophylaxis using Clostridium butyricum for lethal caecitis by Clostridium difficile.Rev.Med.Miclobiol.1997;8:S57-S59.
  • 10[10]Okamoto T,Sasaki M,Tsujikawa T,Fujiyama Y,Bamba T,Kusunoki M.Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats.J Gastroenterol 2000;35:341-346

共引文献18

同被引文献19

  • 1闫合理,闫瑞玲,侯敏,刘炜,王静慧,郑伟.产前超声筛查胎儿先天性心脏病的临床应用研究[J].西北国防医学杂志,2010,31(4):267-269. 被引量:8
  • 2陈慧明,邹继彬.探讨超声心动图诊断胎儿先天性心脏病的价值[J].国际医药卫生导报,2005,11(8):33-34. 被引量:1
  • 3Julia B Ewaschuk,Levinus A Dieleman.Probiotics and prebiotics in chronic inflammatory bowel diseases[J].World Journal of Gastroenterology,2006,12(37):5941-5950. 被引量:41
  • 4Toshio Sawai,Robert Lampman,Yang Hua,Bradley Segura,Robert A. Drongowski,Arnold G. Coran,Caroll M. Harmon.Lysophosphatidylcholine alters enterocyte monolayer permeability via a protein kinase C/Ca2+ mechanism[J].Pediatric Surgery International.2002(7)
  • 5Schnackenberg LK,,Beger RD.Monitoring the health to disease continuum with global metabolic profiling and systems biology[].Pharmacogenomics.2006
  • 6Wiest MM,Watkins SM.Biomarker discovery using high- dimensional lipid analysis[].Current Opinion in Lipidology.2007
  • 7Oresic M,Vidal-Puig A,Hanninen V.Metabolomic approaches to phenotype characterization and applications to complex diseases[].Expert Review of Molecular Diagnostics.2006
  • 8Martin FP,Wang Y,Sprenger N,Yap IK,Lundstedt T,Lek P,Rezzi S,Ramadan Z,van Bladeren P,Fay LB,Kochhar S,Lindon JC,Holmes E,Nicholson JK.Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model[].Mol Syst Biol.2008
  • 9Ezendam J,van Loveren H.Probiotics: immunomodulationand evaluation of safety and efficacy[].Nutrition Reviews.2006
  • 10Galdeano CM,de Moreno de LeBlanc A,Vinderola G,Bonet ME,Perdigon G.Proposed model: mechanisms of immunomodulation induced by probiotic bacteria[].Clin Vaccine Immunol.2007

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部